JPRN-UMIN000046004Recruiting未知
Angiotensin receptor-neprilysin inhibitor in patients with acute myocardial infarction and heart failure - Acute MI and HF registry in Chiba
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Chiba University Hospital
- Enrollment
- 1,000
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Maintenance hemodialysis 2) eGFR <30 ml/min/1.73 m2 3) Failed PCI (TIMI flow grade 0 or 1) 4) In-hospital death
Investigators
Similar Trials
Completed
Not Applicable
Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cancer Risk: A systematic review and network meta-analysisHypertension, Coronary artery disease, Heart failure, Chronic kidney disease, Atrial fibrillation, High risk vascular disease, Cerebrovascular accident, Diabetes mellitus, High normal blood pressure, Pre-hypertensionJPRN-UMIN000048395Yokohama City University Graduate School of Medicine
Recruiting
Unknown
The effect of an angiotensin receptor-neprilysin inhibitor to blood pressure and sympathoadrenal responses during mental arithmetic stress in patients with essential hypertensioessential hypertensionJPRN-UMIN000051537niversity of Toyama40
Active, not recruiting
Phase 1
Effect of the drug sacubitril/valsartan on physical performance in patients with hypertrophic cardiomyopathyhypertrophic cardiomyopathyEUCTR2018-004882-15-DEniversity Hospital Regensburg40
Active, not recruiting
Phase 1
Influences of Sacubitril/Valsartan (ENTRESTO®) on centrally generated sympathetic activity in heart failure patientsChronic heart failure with reduced left ventricular ejection fraction (NYHA II-III)MedDRA version: 20.0Level: LLTClassification code 10078289Term: Heart failure with reduced ejection fractionSystem Organ Class: 100000004849EUCTR2017-000394-36-DEHannover Medical School35
Not yet recruiting
Not Applicable
Effect of angiotensin receptor blockers for neointimal coverage after stent implantation.Hypertensive patients with coronary arteries disease.JPRN-UMIN000007634Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine70
